标题
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-10-02
DOI
10.3389/fimmu.2020.579250
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Key Steps in Vaccine Development
- (2020) Peter L. Stern ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
- (2020) Syed Faraz Ahmed et al. Viruses-Basel
- Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
- (2020) Ning Wang et al. Frontiers in Microbiology
- Deaths in healthcare workers due to COVID‐19: the need for robust data and analysis
- (2020) E. Kursumovic et al. ANAESTHESIA
- Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
- (2020) Huilan Zhang et al. ANNALS OF INTERNAL MEDICINE
- Convalescent plasma in Covid-19: Possible mechanisms of action
- (2020) Manuel Rojas et al. AUTOIMMUNITY REVIEWS
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- A Mouse Model of SARS-CoV-2 Infection and Pathogenesis
- (2020) Shi-Hui Sun et al. Cell Host & Microbe
- Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
- (2020) Hin Chu et al. CLINICAL INFECTIOUS DISEASES
- Is BCG vaccination causally related to reduced COVID‐19 mortality?
- (2020) Masayuki Miyasaka EMBO Molecular Medicine
- Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?
- (2020) Leticia Moreno-Fierros et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immunology of COVID-19: current state of the science
- (2020) Nicolas Vabret et al. IMMUNITY
- SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
- (2020) Uri Hamiel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- The many faces of the anti-COVID immune response
- (2020) Santosha A. Vardhana et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2
- (2020) Kazuma Kiyotani et al. JOURNAL OF HUMAN GENETICS
- Potential of live pathogen vaccines for defeating the COVID‐19 pandemic: history and mechanism
- (2020) Ji‐Wang Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Considering BCG vaccination to reduce the impact of COVID-19
- (2020) Nigel Curtis et al. LANCET
- Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
- (2020) Till Koch et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
- (2020) Pedro M Folegatti et al. LANCET INFECTIOUS DISEASES
- COVID-19 human challenge studies: ethical issues
- (2020) Euzebiusz Jamrozik et al. LANCET INFECTIOUS DISEASES
- A human neutralizing antibody targets the receptor binding site of SARS-CoV-2
- (2020) Rui Shi et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Questions remain following first COVID-19 vaccine results
- (2020) Cormac Sheridan NATURE BIOTECHNOLOGY
- Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
- (2020) Pavan K. Bhatraju et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapid COVID-19 vaccine development
- (2020) Barney S. Graham SCIENCE
- COVID ‐19: are neutralizing antibodies neutralizing enough?
- (2020) Kamran Kadkhoda TRANSFUSION
- Extraordinary diseases require extraordinary solutions
- (2020) Stanley A. Plotkin et al. VACCINE
- Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins
- (2020) Suhas Srinivasan et al. Viruses-Basel
- Immunogenicity of a DNA vaccine candidate for COVID-19
- (2020) Trevor R. F. Smith et al. Nature Communications
- An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
- (2020) Fuzhou Wang et al. MEDICAL SCIENCE MONITOR
- COVID-19: an Immunopathological View
- (2020) Kamran Kadkhoda mSphere
- Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
- (2020) Eun Kim et al. EBioMedicine
- Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
- (2020) Wen Wen et al. Cell Discovery
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiology of COVID‐19: A Systematic Review and Meta‐analysis of Clinical Characteristics, Risk factors and Outcomes
- (2020) Jie Li et al. JOURNAL OF MEDICAL VIROLOGY
- SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
- (2020) Giovanni Salvatori et al. Journal of Translational Medicine
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
- (2020) Parismita Kalita et al. MICROBIAL PATHOGENESIS
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- COVID-19 vaccine development and a potential nanomaterial path forward
- (2020) Matthew D. Shin et al. Nature Nanotechnology
- Amplifying RNA Vaccine Development
- (2020) Deborah H. Fuller et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials
- (2020) Thijs ten Doesschate et al. Trials
- Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers
- (2020) Umit H. Kartoglu et al. VACCINE
- Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2
- (2020) Yi Zhang et al. Nature Communications
- Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS
- (2020) Walter Fierz et al. Frontiers in Immunology
- The laboratory tests and host immunity of COVID-19 patients with different severity of illness
- (2020) Feng Wang et al. JCI Insight
- Coronavirus Pandemic—Therapy and Vaccines
- (2020) Kenneth Lundstrom Biomedicines
- Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
- (2020) Eriko Padron-Regalado Infectious Diseases and Therapy
- Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
- (2020) Tania Gupta et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- What about the original antigenic sin of the humans versus SARS-CoV-2?
- (2020) Luca Roncati et al. MEDICAL HYPOTHESES
- Original Antigenic Sin: How First Exposure Shapes Lifelong Anti–Influenza Virus Immune Responses
- (2019) Ali Zhang et al. JOURNAL OF IMMUNOLOGY
- A Controlled Human Infection Model of Group A Streptococcus Pharyngitis: Which Strain and Why?
- (2019) Joshua Osowicki et al. mSphere
- Non-specific effects of BCG vaccine on viral infections
- (2019) S.J.C.F.M. Moorlag et al. CLINICAL MICROBIOLOGY AND INFECTION
- Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
- (2019) Kayvon Modjarrad et al. LANCET INFECTIOUS DISEASES
- Original Antigenic Sin and Respiratory Syncytial Virus Vaccines
- (2019) Ralph A. Tripp et al. Vaccines
- CEPI: Driving Progress Towards Epidemic Preparedness And Response
- (2019) Dimitrios Gouglas et al. EPIDEMIOLOGIC REVIEWS
- Peptide-Based Vaccines: Current Progress and Future Challenges
- (2019) Ryan J. Malonis et al. CHEMICAL REVIEWS
- Mucosal vaccines: Strategies and challenges
- (2019) Miao Li et al. IMMUNOLOGY LETTERS
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- Effect of sex on vaccination outcomes: important but frequently overlooked
- (2018) Alice Harper et al. CURRENT OPINION IN PHARMACOLOGY
- Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis
- (2018) Jason K. H. Lee et al. Expert Review of Vaccines
- Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape
- (2018) Lingshu Wang et al. JOURNAL OF VIROLOGY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- Recent Advances in Vaccine Technologies
- (2018) Michael James Francis VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE
- Opinion: Making Inactivated and Subunit-Based Vaccines Work
- (2018) Brendon Y. Chua et al. VIRAL IMMUNOLOGY
- DNA Vaccines—How Far From Clinical Use?
- (2018) Dominika Hobernik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Nanoparticle Vaccines Against Infectious Diseases
- (2018) Rashmirekha Pati et al. Frontiers in Immunology
- Original antigenic sin: A comprehensive review
- (2017) Anup Vatti et al. JOURNAL OF AUTOIMMUNITY
- Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies
- (2017) Marc Rondy et al. JOURNAL OF INFECTION
- Rapid Protective Effects of Early BCG on Neonatal Mortality Among Low Birth Weight Boys: Observations From Randomized Trials
- (2017) Sofie Biering-Sørensen et al. JOURNAL OF INFECTIOUS DISEASES
- CEPI—a new global R&D organisation for epidemic preparedness and response
- (2017) Børge Brende et al. LANCET
- Typhoid vaccine development with a human challenge model
- (2017) Nicholas A Feasey et al. LANCET
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis
- (2017) Alexander Domnich et al. VACCINE
- Vaccines for epidemic infections and the role of CEPI
- (2017) Stanley A. Plotkin Human Vaccines & Immunotherapeutics
- Herpes zoster and the search for an effective vaccine
- (2016) N. Arnold et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Sex-differential heterologous (non-specific) effects of vaccines: an emerging public health issue that needs to be understood and exploited
- (2016) Katie L. Flanagan et al. Expert Review of Vaccines
- Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
- (2016) Julian P T Higgins et al. BMJ-British Medical Journal
- Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
- (2016) Anurodh Shankar Agrawal et al. Human Vaccines & Immunotherapeutics
- Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
- (2016) Julian P T Higgins et al. BMJ-British Medical Journal
- Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity
- (2016) Mee Sook Park et al. Immune Network
- Evaluation of candidate vaccine approaches for MERS-CoV
- (2015) Lingshu Wang et al. Nature Communications
- Genetic drift of human coronavirus OC43 spike gene during adaptive evolution
- (2015) Lili Ren et al. Scientific Reports
- BCG-induced trained immunity in NK cells: Role for non-specific protection to infection
- (2014) Johanneke Kleinnijenhuis et al. CLINICAL IMMUNOLOGY
- T cell-mediated immune response to respiratory coronaviruses
- (2014) Rudragouda Channappanavar et al. IMMUNOLOGIC RESEARCH
- Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
- (2014) F. Yasui et al. JOURNAL OF IMMUNOLOGY
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
- (2012) J. Kleinnijenhuis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory T Cells in Arterivirus and Coronavirus Infections: Do They Protect Against Disease or Enhance it?
- (2012) Thomas E. Cecere et al. Viruses-Basel
- Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
- (2011) F. Tang et al. JOURNAL OF IMMUNOLOGY
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- Retinoic Acid as a Vaccine Adjuvant Enhances CD8+ T Cell Response and Mucosal Protection from Viral Challenge
- (2011) X. Tan et al. JOURNAL OF VIROLOGY
- Vaccination in the elderly
- (2011) Evelyna Derhovanessian et al. Microbial Biotechnology
- Coronavirus Diversity, Phylogeny and Interspecies Jumping
- (2009) Patrick C. Y. Woo et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- SARS vaccines: where are we?
- (2009) Rachel L Roper et al. Expert Review of Vaccines
- CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations
- (2009) Dennis Christensen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model
- (2008) N. Tonomura et al. BLOOD
- Peptide Nanoparticles as Novel Immunogens: Design and Analysis of a Prototypic Severe Acute Respiratory Syndrome Vaccine
- (2008) Tais A. P. F. Pimentel et al. Chemical Biology & Drug Design
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now